Copyright
©The Author(s) 2015.
World J Exp Med. May 20, 2015; 5(2): 110-119
Published online May 20, 2015. doi: 10.5493/wjem.v5.i2.110
Published online May 20, 2015. doi: 10.5493/wjem.v5.i2.110
Figure 1 In non-diabetic patients, L-arginine by far outweighs asymmetric dimethylarginine, and active nitrogen oxide modulates vascular tone and structure.
DDAH: Dimethylarginine dimethylaminohydrolase; ADMA: Asymmetric dimethylarginine; LDL: Low-density lipoprotein; NO: Nitrogen oxides.
- Citation: Konya H, Miuchi M, Satani K, Matsutani S, Yano Y, Tsunoda T, Ikawa T, Matsuo T, Ochi F, Kusunoki Y, Tokuda M, Katsuno T, Hamaguchi T, Miyagawa JI, Namba M. Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus. World J Exp Med 2015; 5(2): 110-119
- URL: https://www.wjgnet.com/2220-315X/full/v5/i2/110.htm
- DOI: https://dx.doi.org/10.5493/wjem.v5.i2.110